These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 34058170

  • 1. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.
    Albright BB, Myers ER, Moss HA, Ko EM, Sonalkar S, Havrilesky LJ.
    Am J Obstet Gynecol; 2021 Nov; 225(5):513.e1-513.e19. PubMed ID: 34058170
    [Abstract] [Full Text] [Related]

  • 2. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB, Shorter JM, Mastroyannis SA, Ko EM, Schreiber CA, Sonalkar S.
    Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
    [Abstract] [Full Text] [Related]

  • 3. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P, Hajri T, Massardier J, Lotz JP, Devouassoux-Shisheboran M, Allias Montmayeur F, You B, Golfier F, Bolze PA.
    Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [Abstract] [Full Text] [Related]

  • 4. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Hajri T, Massoud M, Vergne M, Descargues P, Allias F, You B, Lotz JP, Haesebaert J, Bolze PA, Golfier F, Massardier J.
    Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
    [Abstract] [Full Text] [Related]

  • 5. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA, Joseph NT, Melamed A, Sun SY, Goodwin B, Bernstein M, Goldstein DP, Berkowitz RS, Horowitz NS.
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [Abstract] [Full Text] [Related]

  • 6. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG.
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [Abstract] [Full Text] [Related]

  • 7. [Gestational trophoblastic neoplasia after spontaneous normalization of human chorionic gonadotropin in patient with partial hydatidiform mole].
    Matos M, Ferraz L, Lopes Pde F, Lozoya C, Amim Junior J, Rezende-Filho J, Braga A.
    Rev Bras Ginecol Obstet; 2015 Jul; 37(7):339-43. PubMed ID: 26247255
    [Abstract] [Full Text] [Related]

  • 8. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
    Lin LH, Maestá I, St Laurent JD, Hasselblatt KT, Horowitz NS, Goldstein DP, Quade BJ, Sun SY, Braga A, Fisher RA, Berkowitz RS, Elias KM.
    Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
    [Abstract] [Full Text] [Related]

  • 9. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
    Jiao L, Wang Y, Jiang J, Wang X, Zhang W, Zhu C, Xiang Y.
    Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
    [Abstract] [Full Text] [Related]

  • 10. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
    Asmar FTC, Braga-Neto AR, de Rezende-Filho J, Villas-Boas JMS, Charry RC, Maesta I.
    Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
    [Abstract] [Full Text] [Related]

  • 11. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C, Short D, Jackson L, Sebire NJ, Kaur B, Harvey R, Savage PM, Seckl MJ.
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [Abstract] [Full Text] [Related]

  • 12. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
    Lavie I, Rao GG, Castrillon DH, Miller DS, Schorge JO.
    Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
    [Abstract] [Full Text] [Related]

  • 13. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A, Maestá I, Rocha Soares R, Elias KM, Custódio Domingues MA, Barbisan LF, Berkowitz RS.
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [Abstract] [Full Text] [Related]

  • 14. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
    Joyce CM, Coulter J, Kenneally C, McCarthy TV, O'Donoghue K.
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
    [Abstract] [Full Text] [Related]

  • 15. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE, Hancock BW, Short D, Harvey RA, Fisher RA, Drew D, Sarwar N, Tidy JA, Winter MC, Chien P, Seckl MJ.
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [Abstract] [Full Text] [Related]

  • 16. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ, Joseph NT, Berkowitz RS, Goldstein DP.
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [Abstract] [Full Text] [Related]

  • 17. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A, Biscaro A, do Amaral Giordani JM, Viggiano M, Elias KM, Berkowitz RS, Seckl MJ.
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [Abstract] [Full Text] [Related]

  • 18. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A, Andrade T, do Carmo Borges de Souza M, Campos V, Freitas F, Maestá I, Sun SY, Pedrotti LG, Bessel M, Junior JA, Filho JR, Elias KM, Horowitz NS, Berkowitz RS.
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [Abstract] [Full Text] [Related]

  • 19. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB, Granai CO, Ball HG, Curry SL.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [Abstract] [Full Text] [Related]

  • 20. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
    Sato A, Usui H, Shozu M.
    Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.